D'ASSANTE, ROBERTA
 Distribuzione geografica
Continente #
AS - Asia 2.239
EU - Europa 1.835
NA - Nord America 1.791
SA - Sud America 392
AF - Africa 72
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.337
Nazione #
US - Stati Uniti d'America 1.700
SG - Singapore 1.120
RU - Federazione Russa 912
CN - Cina 562
IT - Italia 368
BR - Brasile 308
HK - Hong Kong 195
VN - Vietnam 191
DE - Germania 116
FR - Francia 92
NL - Olanda 75
GB - Regno Unito 64
FI - Finlandia 51
UA - Ucraina 50
CA - Canada 49
IN - India 49
AR - Argentina 42
MX - Messico 33
IE - Irlanda 26
KR - Corea 25
SE - Svezia 25
CI - Costa d'Avorio 23
ZA - Sudafrica 22
AT - Austria 17
BD - Bangladesh 17
EC - Ecuador 15
CO - Colombia 13
IQ - Iraq 9
JP - Giappone 9
ID - Indonesia 8
PL - Polonia 8
TR - Turchia 8
AU - Australia 7
MA - Marocco 7
PK - Pakistan 7
KZ - Kazakistan 5
DZ - Algeria 4
ES - Italia 4
JO - Giordania 4
KE - Kenya 4
MY - Malesia 4
UZ - Uzbekistan 4
VE - Venezuela 4
BE - Belgio 3
CL - Cile 3
EG - Egitto 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
SI - Slovenia 3
UG - Uganda 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CU - Cuba 2
GR - Grecia 2
IR - Iran 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ML - Mali 1
MT - Malta 1
NE - Niger 1
NI - Nicaragua 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.337
Città #
Singapore 516
Moscow 235
Chandler 228
Hong Kong 193
Beijing 169
Hefei 159
Ashburn 147
Santa Clara 90
Naples 78
Ho Chi Minh City 62
Los Angeles 60
Millbury 51
Amsterdam 47
Dallas 46
Napoli 42
Munich 40
Jacksonville 38
Hanoi 36
Wilmington 35
São Paulo 34
Des Moines 33
Houston 30
Nanjing 30
Dong Ket 28
Seattle 27
Buffalo 25
Princeton 25
Redondo Beach 25
New York 24
Seoul 24
Boston 21
Lawrence 19
London 19
Turku 19
Mexico City 18
Ottawa 17
Salerno 16
Pune 15
Milan 14
The Dalles 14
Montreal 13
Nuremberg 13
Poplar 13
Stockholm 13
Brooklyn 12
Orem 12
Chicago 11
Falkenstein 10
Frankfurt am Main 10
Helsinki 10
Rio de Janeiro 10
Falls Church 9
Toronto 9
Vienna 9
Atlanta 8
Council Bluffs 8
Phoenix 8
Quito 8
Tianjin 8
Tokyo 8
Woodbridge 8
Bogotá 7
Da Nang 7
Denver 7
Rome 7
Brasília 6
Chennai 6
Curitiba 6
Düsseldorf 6
Gragnano 6
Haiphong 6
Johannesburg 6
Ribeirão Preto 6
Boardman 5
Campinas 5
Changsha 5
Columbus 5
Delhi 5
Dhaka 5
Dublin 5
Hebei 5
Manchester 5
Mcallen 5
Monza 5
Redwood City 5
Sydney 5
Warsaw 5
Xi'an 5
Amman 4
Bengaluru 4
Biên Hòa 4
Bắc Giang 4
Calvizzano 4
Cambridge 4
Fairfield 4
Guangzhou 4
Lappeenranta 4
Manaus 4
Mumbai 4
Nairobi 4
Totale 3.158
Nome #
DiGeorge-like syndrome in a child with a 3p12.3 deletion involving miRNA-4273 born to a diabetic mother 215
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 194
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice 169
Gamma chain is prominently overexpressed in B-pre acute lymphoblastic leukemia cells 145
Intrathecal amphotericin B therapy in a patient with X-linked chronic granulomatous disease and refractory cerebral invasive aspergillosis 140
Chronic mucocutaneous candidiasis, recurrent herpetic infections and suppurative eyelid infections in a patient carrying a novel gain-of-function mutation in the STAT1 DNA-binding domain 138
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 136
DiGeorge-like Syndrome in a Child with a 3p12.3 Deletion Involving MIR4273 Gene Born to a Mother with Gestational Diabetes Mellitus 134
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction 133
Aberrant autophagic vesicles in the lymphocytes from patients affected with Ataxia-Telangiectasia 130
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 123
Human heart shifts from IGF-1 production to utilization with chronic heart failure 115
Severe combined immunodeficiency-an update 115
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 115
The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy 113
Bleeding related to non-vitamin K antagonist oral anticoagulants in emergency department: A "Real-world" snapshot from Southern Italy. On behalf of MIRC-NOAC study group 113
Diagnostics of Primary immunodeficiencies through next-generation sequencing 112
Growth Hormone as Biomarker in Heart Failure 112
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways 111
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide 110
Unraveling the link between ectodermal disorders and primary immunodeficiencies 110
Unbalanced Immune System: Immunodeficiencies and Autoimmunity 109
APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors. 107
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 105
Biomarkers in Pulmonary Hypertension 104
Effects of Exercise on Heart Failure with Preserved Ejection Fraction: An Updated Review of Literature 101
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 101
Combined effects of growth hormone and testosterone replacement treatment in heart failure 99
Molecular evidence for a thymus-independent partial T cell development in a FOXN1-/- athymic human fetus 98
Growth Hormone Therapy in Heart Failure 98
Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne's thread 98
Subclinical hypothyroidism predicts outcome in heart failure: insights from the T.O.S.CA. registry 97
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment 97
Early Left Ventricular Diastolic Dysfunction in Females with Chronic Hyperprolactinemia: A Doppler Echocardiographic Study 96
Abnormal cell-clearance and accumulation of autophagic vesicles in lymphocytes from patients affected with Ataxia-Teleangiectasia 96
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 96
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 95
Targeted next-generation sequencing revealed MYD88 deficiency in a child with chronic yersiniosis and granulomatous lymphadenitis 95
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 94
Testosterone treatment in chronic heart failure. Review of literature and future perspectives 92
Beneficial metabolic effect of a nutraceuticals combination (Monacolin k, yeasted red rice, polyphenolic extract of annurca apple and berberine) on acquired hypercholesterolemia: A prospective analysis 92
Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 91
Anabolic Deficiencies in Heart Failure: Ready for Prime Time? 90
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 90
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre 87
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction 86
Thymic stromal alterations and genetic disorders of immune system 86
Modulating NO–GC Pathway in Pulmonary Arterial Hypertension 84
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction 84
Metabolic Syndrome in Heart Failure: Friend or Foe? 84
Anabolic Deficiencies in Heart Failure: Ready for Prime Time? 80
Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives 80
Growth hormone in heart failure revisited: An old story retold 78
Postoperative myocardial injury: Trying to square the circle 78
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure 78
Implementing an ICT-Based Polypharmacy Management Program in Italy 73
Biomarkers in Heart Failure: Clinical Insights 72
Biomarkers and Imaging: Complementary or Subtractive? 69
Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone 66
Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities 63
Idiopathic pulmonary fibrosis telemedicine management during COVID-19 outbreak 51
The role of curcumin in liver diseases 47
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry 47
Anabolic Hormone Deficiencies in Heart Failure with Reduced or Preserved Ejection Fraction and Correlation with Plasma Total Antioxidant Capacity 40
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction 19
Totale 6.476
Categoria #
all - tutte 20.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 12 14 6 19 8 18 32
2021/2022293 7 2 14 3 6 11 7 3 32 24 81 103
2022/2023533 50 53 10 33 62 57 19 49 99 56 33 12
2023/2024391 21 55 30 36 23 44 12 75 13 6 47 29
2024/20252.040 86 71 15 20 55 122 197 126 141 205 833 169
2025/20262.595 426 414 466 408 745 136 0 0 0 0 0 0
Totale 6.476